Gauging the Molecular Signatures of Progressive Pulmonary Fibrosis Patients Across Disease Progression
Time: 12:00 pm
day: Day Two Track A AM
Details:
• Examining the physiological lung heterogeneity before disease and its implications on disease biology
• Enhancing understanding of molecular changes including temporal progression and spatial progression to identify the critical players driving the transition
• Exploring metabolomic and epi-proteomic signatures for a deeper understanding of environmental impact